Exploring the Links between Obesity and Psoriasis: A Comprehensive Review
Obesity is a major public health issue worldwide since it is associated with the development of chronic comorbidities such as type 2 diabetes, dyslipidemias, atherosclerosis, some cancer forms and skin diseases, including psoriasis. Scientific evidence has indicated that the possible link between obesity and psoriasis may be multifactorial, highlighting dietary habits, lifestyle, certain genetic factors and the microbiome as leading factors in the progress of both pathologies because they are associated with a chronic pro-inflammatory state. Thus, inflammation management in obesity is a plausible target for psoriasis, not only because of the sick adipose tissue secretome profile but also due to the relationship of obesity with the rest of the immune derangements associated with psoriasis initiation and maintenance. Hence, this review will provide a general and molecular overview of the relationship between both pathologies and present recent therapeutic advances in treating this problem.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Nutrients
5 publications, 6.49%
|
|
|
International Journal of Molecular Sciences
5 publications, 6.49%
|
|
|
Frontiers in Immunology
5 publications, 6.49%
|
|
|
Medicina
3 publications, 3.9%
|
|
|
Clinical, Cosmetic and Investigational Dermatology
3 publications, 3.9%
|
|
|
Medicine (United States)
3 publications, 3.9%
|
|
|
Actas Dermo-Sifiliograficas
2 publications, 2.6%
|
|
|
Journal of Clinical Medicine
2 publications, 2.6%
|
|
|
Scientific Reports
2 publications, 2.6%
|
|
|
Surgery for Obesity and Related Diseases
2 publications, 2.6%
|
|
|
Experimental Dermatology
2 publications, 2.6%
|
|
|
Journal of the European Academy of Dermatology and Venereology
2 publications, 2.6%
|
|
|
Genes
1 publication, 1.3%
|
|
|
Journal of Personalized Medicine
1 publication, 1.3%
|
|
|
Journal of Dermatology
1 publication, 1.3%
|
|
|
Dermatologic Therapy
1 publication, 1.3%
|
|
|
Voprosy Sovremennoi Pediatrii - Current Pediatrics
1 publication, 1.3%
|
|
|
Obesity Medicine
1 publication, 1.3%
|
|
|
Signal Transduction and Targeted Therapy
1 publication, 1.3%
|
|
|
Clinical Interventions in Aging
1 publication, 1.3%
|
|
|
European Journal of Pharmacology
1 publication, 1.3%
|
|
|
Frontiers in Endocrinology
1 publication, 1.3%
|
|
|
Frontiers in Cellular and Infection Microbiology
1 publication, 1.3%
|
|
|
Genes and Immunity
1 publication, 1.3%
|
|
|
Molecular Nutrition and Food Research
1 publication, 1.3%
|
|
|
Expert Review of Clinical Pharmacology
1 publication, 1.3%
|
|
|
Microbiome Research Reports
1 publication, 1.3%
|
|
|
Journal of Autoimmunity
1 publication, 1.3%
|
|
|
Frontiers in Nutrition
1 publication, 1.3%
|
|
|
1
2
3
4
5
|
Publishers
|
2
4
6
8
10
12
14
16
18
20
|
|
|
MDPI
19 publications, 24.68%
|
|
|
Springer Nature
12 publications, 15.58%
|
|
|
Elsevier
11 publications, 14.29%
|
|
|
Frontiers Media S.A.
9 publications, 11.69%
|
|
|
Taylor & Francis
7 publications, 9.09%
|
|
|
Wiley
7 publications, 9.09%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 3.9%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 2.6%
|
|
|
Paediatrician Publishers LLC
1 publication, 1.3%
|
|
|
Research Square Platform LLC
1 publication, 1.3%
|
|
|
OAE Publishing Inc.
1 publication, 1.3%
|
|
|
IntechOpen
1 publication, 1.3%
|
|
|
Oxford University Press
1 publication, 1.3%
|
|
|
Edizioni Minerva Medica
1 publication, 1.3%
|
|
|
2
4
6
8
10
12
14
16
18
20
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.